![James Stonecypher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Stonecypher
Corporate Officer/Principal chez
TELIX PHARMACEUTICALS LIMITED
Profil
James Stonecypher currently works at Object Pharma, Inc., as Chief Executive Officer and Telix Pharmaceuticals Ltd., as Chief Development Officer from 2023.
Mr. Stonecypher received his undergraduate degree from the University of Southern California and graduate degree from The Johns Hopkins University.
Postes actifs de James Stonecypher
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/12/2022 |
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Directeur Général | - |
Formation de James Stonecypher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Health Technology |
